Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/2077Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | REG NO:BG0122011 | - |
| dc.date.accessioned | 2026-01-14T08:14:18Z | - |
| dc.date.available | 2026-01-14T08:14:18Z | - |
| dc.date.issued | 2025 | - |
| dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/2077 | - |
| dc.description.abstract | Introduction: Distinguishing between alcoholic liver disease (ALD) and non alcoholic fatty liver disease (NAFLD) poses a significant clinical challenge due to overlapping histopathological features, particularly when patient history regarding alcohol consumption is unreliable. The Alcoholic Liver Disease/Non Alcoholic Fatty Liver Disease Index (ANI) has emerged as a promising non invasive biomarker to differentiate between these conditions, potentially obviating the need for liver biopsy. This study aimed to evaluate the diagnostic accuracy of the ANI scoring system in distinguishing ALD from NAFLD in a tertiary care setting. | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | KLE Academy of Higher Education and Research, Belagavi | en_US |
| dc.subject | Alcoholic liver disease; Non alcoholic fatty liver disease; ANI score; Non invasive biomarker; Liver fibrosis; Transaminases; SGOT/SGPT ratio; Fibroscan; Diagnostic accuracy | en_US |
| dc.title | Diagnostic value of alcoholic liver disease / non alcoholic fatty liver disease index ( ani ) in differentiating alcoholic liver disease and non alcoholic fatty liver disease one year based observational study in teritary care centre | en_US |
| dc.type | Dissertations | en_US |
| Appears in Collections: | General Medicine MD | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| BG0122011.pdf | 3.07 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.